Baker Avenue Asset Management’s Boston Scientific BSX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$544K	Sell	8,668 -19,153	-69%	-$1.53M	0.01%	402
2025 Q4	$2.65M	Buy	27,821 +1,190	+4%	+$117K	0.06%	188
2025 Q3	$2.6M	Buy	26,631 +543	+2%	+$56.2K	0.06%	189
2025 Q2	$2.8M	Sell	26,088 -1,410	-5%	-$143K	0.08%	166
2025 Q1	$2.77M	Buy	+27,498	New	+$2.77M	0.09%	171
2023 Q4	–	Sell	-167	Closed	-$8.82K	–	525
2023 Q3	$8.82K	Sell	167 -53	-24%	-$2.78K	﹤0.01%	790
2023 Q2	$11.9K	Buy	220 +14	+7%	+$731	﹤0.01%	716
2023 Q1	$10.3K	Sell	206 -29	-12%	-$1.37K	﹤0.01%	760
2022 Q4	$10.9K	Buy	+235	New	+$10.2K	﹤0.01%	694
2019 Q3	–	Sell	-5,593	Closed	-$240K	–	240
2019 Q2	$240K	Buy	+5,593	New	+$215K	0.02%	221
2017 Q2	–	Sell	-24,268	Closed	-$604K	–	202
2017 Q1	$604K	Buy	24,268 +1,823	+8%	+$44.3K	0.08%	131
2016 Q4	$485K	Buy	22,445 +2,220	+11%	+$48.4K	0.07%	149
2016 Q3	$481K	Buy	20,225 +655	+3%	+$15.6K	0.07%	141
2016 Q2	$457K	Sell	19,570 -390	-2%	-$8.44K	0.07%	136
2016 Q1	$375K	Sell	19,960 -3,640	-15%	-$63.9K	0.06%	142
2015 Q4	$435K	Buy	+23,600	New	+$423K	0.06%	128